Inventor · disambiguated record
Andre Pelegrin
Also filed as: PELEGRIN ANDRE · PELEGRIN ANDRÉ
15 granted patents·5 pending applications·66 citations·filing 1994–2023
90Inventor score
Files withINST NAT SANTE RECH MED6BIOMUNEX PHARMACEUTICALS2ROBERT BRUNO2TEULON ISABELLE2BATY DANIEL1
Top patents by PatentIndex Score
20 records- 0188US10385137B2Production of antibody formats and immunological applications of said formatsINST NAT SANTE RECH MED·Filed 2015·Granted Aug 20, 2019·12 cites·3 claims
- 0288US9169316B2Production of antibody formats and immunological applications of said formatsBATY DANIEL·Filed 2007·Granted Oct 27, 2015·26 cites·10 claims
- 0380US8278423B2Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)TEULON ISABELLE·Filed 2007·Granted Oct 2, 2012·7 cites·13 claims
- 0477US9458239B2Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)TEULON ISABELLE·Filed 2012·Granted Oct 4, 2016·4 cites·19 claims
- 0575US9127065B2Anti-human HER3 antibodies and uses thereofCHARDES THIERRY·Filed 2012·Granted Sep 8, 2015·5 cites·13 claims
- 0665US9409988B2Anti-Axl antibodies and uses thereofROBERT BRUNO·Filed 2012·Granted Aug 9, 2016·1 cites·17 claims
- 0761US9249228B2Anti-Axl antibodies and uses thereofROBERT BRUNO·Filed 2012·Granted Feb 2, 2016·1 cites·15 claims
- 0857US2025282892A1Bispecific antibodies binding to her-3 and to either her-2 or egfrBIOMUNEX PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0953US12441788B2Anti-müllerian inhibiting substance antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2020·Granted Oct 14, 2025·0 cites·12 claims
- 1051US7892542B2Human anti-idiotypic antibody fragments that mimic HER-2/neuINST NAT SANTE RECH MED·Filed 2004·Granted Feb 22, 2011·0 cites·13 claims
- 1148US10196455B2Neuregulin allosteric anti-HER3 antibodyINST NAT SANTE RECH MED·Filed 2013·Granted Feb 5, 2019·0 cites·14 claims
- 1248US9522956B2Combination therapy using anti-EGFR and anti-HER2 antibodiesL'INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2014·Granted Dec 20, 2016·0 cites·15 claims
- 1346US2009214541A1Combination Therapy Using Anti-EGFR and Anti-HER2 AntibodiesINSTUT NAT DE LA SANTE ET DE L·Filed 2006·Application pending·0 cites
- 1445US5672513ACarcino-embryonic antigen derivatives lacking the carboxyl terminal endROCHE DIAGNOSTIC SYSTEMS INC·Filed 1994·Granted Sep 30, 1997·10 cites·3 claims
- 1545US2022290151A1Use of müllerian inhibiting substance inhibitors for treating cancerINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1640US2011110929A1Human anti-idiotypic antibody fragments that mimic her-2/neuGAUTHIER PHILIPPE·Filed 2011·Application pending·0 cites
- 1737US2018291098A1Anti-nrg1 (heregulin) antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 1836US12054550B2Bispecific antibodies targeting EGFR and HER2BIOMUNEX PHARMACEUTICALS·Filed 2017·Granted Aug 6, 2024·0 cites·10 claims
- 1934US9346883B2Antibodies against HER3KHARRAT ABDELHAKIM·Filed 2012·Granted May 24, 2016·0 cites·12 claims
- 2033US11001634B2Anti-human-HER3 antibodies and uses thereofGAMAMABS PHARMA·Filed 2016·Granted May 11, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Andre Pelegrin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →